Sponsor Pipeline

Johann E Gudjonsson MD PhD Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 4
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT06906497 Lebrikizumab in Moderate-to-severe Atopic Dermatitis Atopic Dermatitis Recruiting
Disease Areas
Atopic Dermatitis (1)
Get alerts when Johann E Gudjonsson MD PhD's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free